Todd Stottlemeyer is the CEO and a Board Member at Acentra Health, a private equity backed healthcare technology solutions and services company. He led the successful sale of CNSI to The Carlyle Group and the acquisition of and merger with Kepro. Today, the combined company, now Acentra Health, employs approximately 3,000 people and operates across the U.S. and in India. He is a Venture Fellow at Blue Delta Capital Partners, a growth venture capital firm focused on partnering with and investing in promising companies that are delivering technology-enabled solutions and services to the U.S. Federal Government.